Chemodenervation and Nerve Blocks in the Diagnosis and Management of Spasticity and Muscle Overactivity

PM and R

Volumn 1, Issue 9, 2009, Pages 842-851

  Elovic, Elie P ^a   Esquenazi, Alberto ^b   Alter, Katharine E ^c   Lin, John L ^d   Alfaro, Abraham ^e   Kaelin, Darryl L ^d  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b Moss Rehab Hospital   (United States)

^c Mt Washington Pediatric Hospital   (United States)

^d SHEPHERD CENTER   (United States)

^e Bacharach Institute for Rehab   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; BACLOFEN; BOTULINUM TOXIN A; BOTULINUM TOXIN B; PHENOL;

CERVICAL DYSTONIA; CLINICAL EVALUATION; CLINICAL PROTOCOL; CLINICAL TRIAL; DRUG CHOICE; DRUG CONTRAINDICATION; DRUG COST; DRUG DOSE COMPARISON; ECHOGRAPHY; ELECTROMYOGRAM; ELECTROSTIMULATION; FATIGUE; GAIT; HEADACHE; HUMAN; INJECTION PAIN; LOW DRUG DOSE; MUSCLE DENERVATION; MUSCLE HYPERTONIA; NERVE BLOCK; NEUROLYSIS; PHYSIOTHERAPY; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SHOULDER; SPASTICITY; TISSUE DISTRIBUTION;

BOTULINUM TOXINS; BOTULINUM TOXINS, TYPE A; HUMANS; MUSCLE DENERVATION; MUSCLE SPASTICITY; NERVE BLOCK; NEUROMUSCULAR AGENTS; PHENOL; SYMPATHECTOMY, CHEMICAL;

EID: 70349193720     PISSN: 19341482     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pmrj.2009.08.001     Document Type: Review

References (98)

1. Schroeder A.S., Berweck S., Lee S.H., and Heinen F. Botulinum toxin treatment of children with cerebral palsy-a short review of different injection techniques. Neurotox Res 9 (2006) 189-196
2. Fanucci E., Masala S., Squillaci E., et al. Pyriformis muscle syndrome: CT/MR findings in the percutaneous therapy with botulinic toxin. Radiol Med 105 (2003) 69-75
3. Jankovic J. Review. Treatment of cervical dystonia with botulinum toxin. Mov Disord 19 Suppl 8 (2004) S109-S115
4. Dogu O., Apaydin D., Sevim S., Talas D.U., and Aral M. Ultrasound-guided versus 'blind' injection of botulinum toxin-A for treatment of sialorrhoea in patients with Parkinson's disease. Clin Neurol Neurosurg 106 (2004) 93-96
5. Yang E.J., Rha D., Yoo J.K., and Park E.S. Accuracy of manual needle placement for gastrocnemius muscle in children with cerebral palsy checked against ultrasonography. Arch Phys Med Rehabil 90 (2009) 741-744
6. Westoff B., Seller K., Wild A., Jaeger M., and Krauspe R. Ultrasound guided botulinum toxin injection technique for the iliopsoas. Dev Med Child Neurol 45 (2003) 829-832
7. Lee L.H., Chang W.N., and Chang C.S. The finding and evaluation of EMG-guided BOTOX injection in cervical dystonia. Acta Neurol Taiwan 13 (2004) 71-76
8. Cordivari C., Misra V.P., Vincent A., Catania S., Bhatia K.P., and Lees A.J. Secondary nonresponsiveness to botulinum toxin A in cervical dystonia: The role of electromyogram-guided injections, botulinum toxin A antibody assay, and the extensor digitorum brevis test. Mov Disord 21 (2006) 1737-1741
9. Lim E.C., Quek A.M., and Seet R.C. Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: Pilot study. Neurol Neurophysiol Neurosci Jun 30 (2006) 4
10. Chin T.Y., Nattrass G.R., Selber P., and Graham H.K. Accuracy of intramuscular injection of botulinum toxin A in juvenile cerebral palsy: A comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop 25 (2005) 286-291
11. Molloy F.M., Shill H.A., Kaelin-Lang A., and Karp B.I. Accuracy of muscle localization without EMG: Implications for treatment of limb dystonia. Neurology 58 (2002) 805-807
12. Mayer N.H., Whyte J., Wannstedt G., and Ellis C.A. Comparative impact of 2 botulinum toxin injection techniques for elbow flexor hypertonia. Arch Phys Med Rehabil 89 (2008) 982-987
13. Geenen C., Consky E., and Ashby P. Localizing muscles for botulinum toxin treatment of focal hand dystonia. Can J Neurol Sci 23 (1996) 194-197
14. Childers M.K. The importance of electromyographic guidance and electrical stimulation for injection of botulinum toxin. Phys Med Rehabil Clin N Am 14 (2003) 781-792
15. Lim E.C., Ong B.K., and Seet R.C. Botulinum toxin-A injections for spastic toe clawing. Parkins Rel Disord 12 (2006) 43-47
16. O'Brien C.F. Injection techniques for botulinum toxin using electromyography and electrical stimulation. Muscle Nerve Suppl 6 (1997) S176-S180
17. Hogan Q. Finding nerves is not simple. Reg Anesth Pain Med 28 (2003) 367-371
18. Chin K.J., and Chan V. Ultrasound-guided peripheral nerve blockade. Curr Opin Anaesthesiol 21 (2008) 624-631
19. Brull R., Perla A., Cheng P.H., et al. Minimizing the risk of intravascular injection during ultrasound-guided peripheral nerve blockade. Anesthesiology 109 (2008) 1142-1143
20. Perlas A., Niazi A., McCartney C., et al. The sensitivity of motor response to nerve stimulation and paresthesia for nerve localization as evaluated by ultrasound. Reg Anesth Pain Med 31 (2006) 445-450
21. Casati A., Danelli G., Baciarello M., et al. A prospective, randomized comparison between ultrasound and nerve stimulation guidance for multiple injection axillary brachial plexus block. Anesthesiology 106 (2007) 992-996
22. Dhir S., and Ganapathy S. Comparative evaluation of ultrasound-guided continuous infraclavicular brachial plexus block with stimulating catheter and traditional technique: A prospective-randomized trial. Acta Anaesthesiol Scand 52 (2008) 1158-1166
23. Dufour E., Quennesson P., Van Robais A.L., et al. Combined ultrasound and neurostimulation guidance for popliteal sciatic nerve block: A prospective, randomized comparison with neurostimulation alone. Anesth Analg 106 (2008) 1553-1558
24. Geffen G.J., Broek E.V., Braak G.J.J., et al. A prospective randomized controlled trial of ultrasound guided versus nerve stimulation guided distal sciatic nerve block at the popliteal fossa. Anaesth Intensive Care 37 (2009) 32-37
25. Reid N., Stella J., Ryan M., and Ragg M. Use of ultrasound to facilitate accurate femoral nerve block in the emergency department. Emerg Med Australas 21 (2009) 124-130
26. Akkaya T., Ozturk E., Comert A., et al. Ultrasound-guided obturator nerve block: A sonoanatomic study of a new methodologic approach. Anesth Analg 108 (2009) 1037-1041
27. Berweck S., and Heinen F. Use of botulinum toxin in pediatric spasticity (cerebral palsy). Mov Disord 19 Suppl 8 (2004) S162-S167
28. Berweck S., Feldkamp A., Francke A., Hehles J., Schwerin A., and Heinen F. Sonography guided injection of botulinum toxin A in children with cerebral palsy. Neuropediatrics 33 (2002) 221-223
29. Willenborg M.J., Shilt J.S., Smith B.P., Estrada R.L., Castle J.A., and Koman L.A. Technique for iliopsoas ultrasound-guided active electromyography-directed botulinum a toxin injection in cerebral palsy. J Pediatr Orthop 22 (2002) 165-168
30. Pena A., Gahill A.M., Gozalez L., Baskin K., Kim H., and Towbin R. Botulinum toxin A injection of salivary glands in children with drooling and chronic aspiration. J Vasc Interv Radiol 20 (2009) 368-373
31. Jordan S., Ahan S., and Gelabert H. Combining ultrasound and EMG for botulinum toxin chemodenervation treatment of thoracic outlet syndrome: Comparison with fluoroscopy and EMG guidance. Pain Physician 10 (2007) 541-546
32. Elovic EP, Eiseberg ME, Jasey NN. Spasticity and muscle overactivity as components of the upper motor neuron syndrome. In: Frontera W, ed. Physical Medicine and Rehabilitation: Principles and Practice. 5th ed. New York: Demos Medical Publishing [in press].
33. DeLateur B.J. A new technique of intramuscular phenol neurolysis. Arch Phys Med Rehabil 53 (1972) 179-181
34. Halpern D., and Meelhuysen F.E. Phenol motor point block in the management of muscular hypertonia. Arch Phys Med Rehabil 47 (1966) 659-664
35. Khalili A.A., Harmel M.H., Forster S., and Benton J.G. Management of spasticity by selective peripheral nerve block with dilute phenol solutions in clinical rehabilitation. Arch Phys Med Rehabil 45 (1964) 513-519
36. Chua K.S., and Kong K.H. Alcohol neurolysis of the sciatic nerve in the treatment of hemiplegic knee flexor spasticity: Clinical outcomes. Arch Phys Med Rehabil 81 (2000) 1432-1435
37. Chua K.S., and Kong K.H. Clinical and functional outcome after alcohol neurolysis of the tibial nerve for ankle-foot spasticity. Brain Inj 15 (2001) 733-739
38. Kong K.H., and Chua K.S. Outcome of obturator nerve block with alcohol for the treatment of hip adductor spasticity. Int J Rehabil Res 22 (1999) 327-329
39. Brashear A., Gordon M.F., Elovic E., et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med 347 (2002) 395-400
40. Elovic E.P., Brashear A., Kaelin D., et al. Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients. Arch Phys Med Rehabil 89 (2008) 799-806
41. Esquenazi A., Mayer N., and Garreta R. Influence of botulinum toxin type A treatment of elbow flexor spasticity on hemiparetic gait. Am J Phys Med Rehabil 87 (2008) 305-310
42. Gordon M.F., Brashear A., Elovic E., et al. Repeated dosing of botulinum toxin type A for upper limb spasticity following stroke. Neurology 63 (2004) 1971-1973
43. Simpson D.M., Gracies J.M., Yablon S.A., Barbano R., Brashear A., and BoNT/TZD Study Team. Botulinum neurotoxin versus tizanidine in upper limb spasticity: A placebo-controlled study. J Neurol Neurosurg Psychiatry 80 (2009) 380-385
44. Bakheit A.M., Thilmann A.F., Ward A.B., et al. A randomized, double-blind, placebo-controlled, dose-ranging study to compare the efficacy and safety of three doses of botulinum toxin type A (Dysport) with placebo in upper limb spasticity after stroke. Stroke 31 (2000) 2402-2406
45. Bakheit A.M., Pittock S., Moore A.P., et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of botulinum toxin type A in upper limb spasticity in patients with stroke. Eur J Neurol 8 (2001) 559-565
46. Bakheit A.M., and Sawyer J. The effects of botulinum toxin treatment on associated reactions of the upper limb on hemiplegic gait-a pilot study. Disabil Rehabil 24 (2002) 519-522
47. Hyman N., Barnes M., Bhakta B., et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: A prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry 68 (2000) 707-712
48. Brashear A., McAfee A.L., Kuhn E.R., and Fyffe J. Botulinum toxin type B in upper-limb poststroke spasticity: A double-blind, placebo-controlled trial. Arch Phys Med Rehabil 85 (2004) 705-709
49. Ozcakir S., and Sivrioglu K. Botulinum toxin in poststroke spasticity. Clin Med Res 5 (2007) 132-138
50. Comella C.L., Jankovic J., Shannon K.M., et al. Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia. Neurology 65 (2005) 1423-1429
51. Gracies J.-M. Pathophysiology of spastic paresis. I: Paresis and soft tissue changes and II: Emergence of muscle overactivity. Muscle Nerve 31 (2005) 535-571
52. Simpson J.-M., Gracies H.K., Graham J.M., et al. Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 70; (2008) 1691-1698
53. Brin M.F. Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology. Muscle Nerve 20 Suppl 6 (1997) S146-S168
54. Yablon S.A., Brashear A., Gordon M.F., et al. Formulation of neutralizing antibodies in patients receiving botulinum toxin type A for treatment of poststroke spasticity: Pooled-data analysis of three clinical trials. Clin Ther 29 (2007) 683-690
55. Radensky P.W., Archer J.W., Dournaux S.F., and O'Brien C.F. The estimated cost of managing focal spasticity: A physician practice patterns survey. Neurorehabil Neural Repair 15 (2001) 57-68
56. Giovannelli M., Borriello G., Castri P., Prosperini L., and Pozzilli C. Early physiotherapy after injection of botulinum toxin increases the beneficial effects on spasticity in patients with multiple sclerosis. Clin Rehabil 21 (2007) 331-337
57. Albany K. Physical and occupational therapy considerations in adult patients receiving botulinum toxin injections for spasticity. Muscle Nerve Suppl 6 (1997) S221-S312
58. Royal College of Physicians. National Clinical Guidelines for Stroke, prepared by the Intercollegiate Stroke Working Party. 2nd ed. (2004), Royal College of Physicians, London
59. Kulkarni J. Efficacy of botulinum toxin for spasticity management in neurorehabilitation. Int J Ther Rehabil 11 (2004) 211-212
60. Robertson A., Ashford S., Heward, et al. The role of physiotherapists in the management of spasticity with botulinum toxin in adults and pediatric patients: A guideline (2006), Medendium Publishing Group Ltd, Berkhamsted, UK
61. Shah S.N., Hornyak J., and Urquhart A.G. Flexion contracture after total knee arthroplasty in a patient with Parkinson's disease: Successful treatment with botulinum toxin type A. J Arthroplasty 20 (2005) 1078-1080
62. Kay R.M., Rethlefsen S.A., Fern-Buneo A., Wren T.A., and Skaggs D.L. Botulinum toxin as an adjunct to serial casting treatment in children with cerebral palsy. J Bone Joint Surg Am 86 (2004) 2377-2384
63. Verplancke D., Snape S., Salisbury C.F., Jones P.W., and Ward A.B. A randomized controlled trial of botulinum toxin on lower limb spasticity following acute acquired severe brain injury. Clin Rehabil 19 (2005) 117-125
64. Taylor N.F., Dodd K.J., Prasad D., and Denisenko S. Progressive resistance exercise for people with multiple sclerosis. Disabil Rehabil 28 (2006) 1119-1126
65. Dibble L.E., Hale T.F., Marcus R.L., Droge J., Gerber J.P., and LaStayo P.C. High-intensity resistance training amplifies muscle hypertrophy and functional gains in persons with Parkinson's disease. Mov Disord 21 (2006) 1444-1452
66. Ada L., Dorsch S., and Canning C.G. Strengthening interventions increase strength and improve activity after stroke: A systematic review. Aust J Physiother 52 (2006) 241-248
67. Scholtes V.A., Dallmeijer A.J., Knol D.L., et al. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: A randomized clinical trial. Arch Phys Med Rehabil 87 (2006) 1551-1558
68. Gracies J.M., Singer B.J., and Dunne J.W. The role of botulinum toxin injections in the management of muscle overactivity of the lower limb. Disabil Rehabil 29 (2007) 1789-1805
69. Dobkin B.H. Training and exercise to drive poststroke recovery. Nat Clin Pract Neurol 4 (2008) 76-85
70. Hesse S. Treadmill training with partial body weight support after stroke: A review. NeuroRehabilitation 23 (2008) 55-65
71. Robertson J.V., Pradon D., Bensmail D., Fermanian C., Bussel B., and Roche N. Relevance of botulinum toxin injection and nerve block of rectus femoris to kinematic and functional parameters of stiff knee gait in hemiplegic adults. Gait Posture 29 (2009) 108-112
72. Bonaiuti D., Rebasti L., and Sioli P. The constraint induced movement therapy: A systematic review of randomized controlled trials on the adult stroke patients. Eura Medicophys 43 (2007) 139-146
73. Levy C.E., Giuffrida C., Richards L., Wu S., Davis S., and Nadeau S.E. Botulinum toxin A, evidence-based exercise therapy, and constraint-induced movement therapy for upper-limb hemiparesis attributable to stroke: A preliminary study. Am J Phys Med Rehabil 86 (2007) 696-706
74. Sun S.F., Hsu C.W., Hwang C.W., Hsu P.T., Wang J.L., and Yang C.L. Application of combined botulinum toxin type A and modified constraint-induced movement therapy for an individual with chronic upper-extremity spasticity after stroke. Phys Ther 86 (2006) 1387-1397
75. Reiter F., Danni M., Lagalla G., Ceravolo G., and Provinciali L. Low-dose botulinum toxin with ankle taping for the treatment of spastic equinovarus foot after stroke. Arch Phys Med Rehabil 79 (1998) 532-535
76. Carda S., and Molteni F. Taping versus electrical stimulation after botulinum toxin type A injection for wrist and finger spasticity. A case-control study. Clin Rehabil 19 (2005) 621-626
77. Hesse S., Jahnke M.T., Luecke D., and Mauritz K.H. Short-term electrical stimulation enhances the effectiveness of botulinum toxin in the treatment of lower limb spasticity in hemiparetic patients. Neurosci Lett 201 (1995) 37-40
78. Eleopra R., Tugnoli V., and De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: The role of muscle activity in humans. Mov Disord 12 (1997) 89-94
79. Bayram S., Sivrioglu K., Karli N., and Ozcan O. Low-dose botulinum toxin with short-term electrical stimulation in poststroke spastic drop foot: A preliminary study. Am J Phys Med Rehabil 85 (2006) 75-81
80. Esquenazi A., and Mayer N. Abstract. Electric stimulation to prolong the duration of botulinum toxin type A effect on spasticity: A double-blind, placebo-controlled study. Arch Phys Med Rehabil 88E105 (2007)
81. Johnson C.A., Burridge J.H., Strike P.W., Wood D.E., and Swain I.D. The effect of combined use of botulinum toxin type A and functional electric stimulation in the treatment of spastic drop foot after stroke: A preliminary investigation. Arch Phys Med Rehabil 85 (2004) 902-909
82. Gracies J.M., Legacy M., Weiss D.J., Echo M., Flanagan S., and Simpson D.M. Botulinum toxin dilution and endplate targeting in spasticity: A double-blind controlled study. Arch Phys Med Rehabil 90 (2009) 9-16.e2
83. Wessel J., Ward A.B., Retard P., et al. European consensus table on the use of botulinum toxin type A in adult spasticity. J Rehabil Med 41 (2009) 13-25
84. Buffenoir K., Decq P., and Lefaucheur J.P. Interest of peripheral anesthetic blocks as a diagnosis and prognosis tool in patients with spastic equinus foot: A clinical and electrophysiological study of the effects of block of nerve branches to the triceps surae muscle. Clin Neurophysiol 116 (2005) 1596-1600
85. Kishner S. Chemical neurolysis with phenol. An AAEM workshop, October 1998.
86. Shin D.Y., and Lennard T.A. Proximal upper extremity, trunk, and head blocks. In: Lennard T.A. (Ed). Physiatric Procedures in Clinical Practice (1995), Hanley & Belfus, Inc, Philadelphia 130-138
87. Mauldin C.C., and Brooks D.W. Arm, forearm, and hand blocks. In: Lennard T.A. (Ed). Physiatric Procedures in Clinical Practice (1995), Hanley & Belfus, Inc, Philadelphia 139-149
88. Keenan M.A.E., and Botte M.J. Technique of percutaneous phenol block of the recurrent motor branch of the median nerve. J Hand Surg Am 12 (1987) 806-8007
89. Lukban M.B., Rosales R.L., and Dressler D. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: A summary of evidence. J Neural Transm 116 (2009) 319-331
90. Harrison T.P., Sadnicka A., and Eastwood D.M. Motor points for the neuromuscular blockade of the subscapularis muscle. Arch Phys Med Rehabil 88 (2007) 295-297
91. Shin D.Y., and Lennard T.A. Proximal lower extremity blocks. In: Lennard T.A. (Ed). Physiatric Procedures in Clinical Practice (1995), Hanley & Belfus, Inc, Philadelphia 150-156
92. Albert T., Yelnik A., Colle F., Bonan I., and Lassau J.P. Anatomic motor point localization for partial quadriceps block in spasticity. Arch Phys Med Rehabil 81 (2000) 285-287
93. Jang S.H., Ahn S.H., Park S.M., Kim S.H., Lee K.H., and Lee Z.I. Alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle to treat ankle spasticity in patients with hemiplegic stroke. Arch Phys Med Rehabil 85 (2004) 506-508
94. Deltombe T., De Wispelaere J.-F., Gustin T., Jamart J., and Hanson P. Selective blocks of the motor nerve branches to the soleus and tibialis posterior muscles in relation to anatomic surface landmarks for selective motor nerve blocks in the management of the spastic equinovarus foot. Arch Phys Med Rehabil 85 (2004) 54-58
95. Wassef M.R. Interadductor approach to obturator nerve blockade for spastic conditions of adductor thigh muscles. Reg Anesth 18 (1993) 13-17
96. Sung D.H., and Bang H.J. Motor branch block of the rectus femoris: Its effectiveness in stiff-legged gait in spastic paresis. Arch Phys Med Rehabil 81 (2000) 910-915
97. Chantraine F., Detrembleur C., and Lejeune T.M. Effect of the rectus femoris motor branch block on post-stroke stiff-legged gait. Acta Neurol Belg 105 (2005) 171-177
98. Farmer S.E., and James M. Contractures in orthopaedic and neurological conditions: A review of causes and treatment. Disabil Rehabil 23 (2001) 549-558